Denver doctor pleads guilty to illegally prescribing controlled substances
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Denver doctor pleads guilty to illegally prescribing controlled substances

Denver doctor pleads guilty to illegally prescribing controlled substances

October 07, 2019
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Steffan W. Tubbs
Phone Number: 571-387-5079

Dr. Andrew Mark Ho prescribed “Holy Trinity” cocktail of drugs to patients

DENVER – United States Attorney Jason R. Dunn announced that Dr. Andrew Mark Ho, age 54, of Denver, pled guilty yesterday to illegally dispensing or illegally causing to be dispensed oxycodone, a controlled substance.  Ho pled guilty before Chief U.S. District Court Judge Philip B. Brimmer.  Judge Brimmer is scheduled to sentence Ho on January 10, 2020.  The defendant appeared at the change of plea hearing free on bond.  The bond was continued at the conclusion of the hearing.

 

According to the stipulated facts contained in Ho’s plea agreement, Andrew Mark Ho is a medical doctor licensed to practice in the state of Colorado.  Ho was registered with the Drug Enforcement Administration (DEA) until approximately December 13, 2016, authorizing him to write prescriptions for controlled substances on Schedules II through V.  He is an owner of and practices at Harvard Avenue Internal Medicine LLC.  Dr. Ho stipulated that between 2014 and 2016, he prescribed controlled substances comprising the so-called “Holy Trinity,” outside the scope of accepted medical practice. 

 

The “Holy Trinity” is a colloquial term to describe the prescription of a combination of drugs comprised of a benzodiazepine, an opioid, and a muscle relaxant, which while highly sought out on the street, is especially dangerous because each of those medications depress the central nervous system and the ability to breathe. 

 

“Overprescribing controlled substances, especially prescribing the “Holy Trinity” of prescription drugs is dangerous, and there is no acceptable medical reason to do so,” said U.S. Attorney Jason Dunn.  “In this case, it’s simply flat-out drug dealing and is being treated accordingly.”

 

“The DEA is committed to identifying the sources of illicit prescribing and will continue to hold providers and distributors accountable for their actions that denigrate this community,” said DEA Denver Division Acting Special Agent in Charge Deanne Reuter.  “By Dr. Ho relinquishing his ability to prescribe controlled substances, there will be fewer people in this state being provided highly addictive controlled substances for no legitimate medical reason, which in this case resulted in abuse and illegal distribution.”

 

This case was investigated by the DEA.  The defendant was prosecuted by Assistant U.S. Attorneys Hetal J. Doshi and Bryan D. Fields.

Download Press Release
###
Oxycodone
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

David S. Olesky Special Agent in Charge - Rocky Mountain
@DEAROCKYMTNDiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster